130 related articles for article (PubMed ID: 1277189)
1. The effect of allopurinol on cyclophosphamide antitumor activity.
Alberts DS; van Daalen Wetters T
Cancer Res; 1976 Aug; 36(8):2790-4. PubMed ID: 1277189
[TBL] [Abstract][Full Text] [Related]
2. The effect of phenobarbital on cyclophosphamide antitumor activity.
Alberts DS; van Daalen Wetters T
Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
[TBL] [Abstract][Full Text] [Related]
3. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclophosphamide on mouse bone marrow and leukemic stem cells.
Paprocka M; Budzyński W; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1980; 28(3):447-51. PubMed ID: 7447649
[TBL] [Abstract][Full Text] [Related]
5. alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity.
Alberts DS; Peng YM; Moon TE
Biomedicine; 1978 Oct; 29(6):189-91. PubMed ID: 737277
[TBL] [Abstract][Full Text] [Related]
6. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
7. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
Presant CA; Valeriote F; Vietti TJ
Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
10. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
11. [Effect of cyclophosphamide on neuroblastoma and the bone marrow function in the experimental studies].
Ohkawa M
Hokkaido Igaku Zasshi; 1983 Nov; 58(6):561-74. PubMed ID: 6368346
[TBL] [Abstract][Full Text] [Related]
12. Effects of allopurinol on the therapeutic efficacy of methotrexate.
Grindey GB; Moran RG
Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
[TBL] [Abstract][Full Text] [Related]
13. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
Kühl JS; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
[TBL] [Abstract][Full Text] [Related]
14. Detection of lymphoid leukemia colony-forming cells in Abelson virus infected mice: differences in inbred strains.
Earl CD; Scher CD
J Cell Physiol; 1980 Aug; 104(2):153-62. PubMed ID: 7410487
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
16. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cimetidine but not ranitidine with cyclophosphamide in mice.
Dorr RT; Soble MJ; Alberts DS
Cancer Res; 1986 Apr; 46(4 Pt 1):1795-9. PubMed ID: 3948164
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
Paprocka M; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
[TBL] [Abstract][Full Text] [Related]
19. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
